Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Montreal Canada

Organization Overview

First Clinical Trial
2006
NCT00290121
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

desvenlafaxine (pristiq) (1 trial)

duloxetine (Cymbalta) (1 trial)

olanzapine (zyprexa) (1 trial)

Drugs in Phase 3 Trials (1)

cycloserine (seromycin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Schizophrenia (Phase 4)

Stress Disorders, Post-Traumatic (Phase 3)

Stress Disorders, Traumatic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4